US20110118478A1 - Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses - Google Patents

Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses Download PDF

Info

Publication number
US20110118478A1
US20110118478A1 US12/769,302 US76930210A US2011118478A1 US 20110118478 A1 US20110118478 A1 US 20110118478A1 US 76930210 A US76930210 A US 76930210A US 2011118478 A1 US2011118478 A1 US 2011118478A1
Authority
US
United States
Prior art keywords
alkyl
formula
compound
preparation
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US12/769,302
Other versions
US8492590B2 (en
Inventor
Mark James Ford
Gunter Karig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Assigned to BAYER CROPSCIENCE AG reassignment BAYER CROPSCIENCE AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FORD, MARK JAMES, KARIG, GUNTER
Publication of US20110118478A1 publication Critical patent/US20110118478A1/en
Priority to US13/915,898 priority Critical patent/US9242934B2/en
Application granted granted Critical
Publication of US8492590B2 publication Critical patent/US8492590B2/en
Assigned to BAYER INTELLECTUAL PROPERTY GMBH reassignment BAYER INTELLECTUAL PROPERTY GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAYER CROPSCIENCE AG
Assigned to BAYER INTELLECTUAL PROPERTY GMBH reassignment BAYER INTELLECTUAL PROPERTY GMBH CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 034892 FRAME: 0286. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: BAYER CROPSCIENCE AG
Assigned to BAYER INTELLECTUAL PROPERTY GMBH reassignment BAYER INTELLECTUAL PROPERTY GMBH CHANGE OF ADDRESS Assignors: BAYER INTELLECTUAL PROPERTY GMBH
Assigned to BAYER CROPSCIENCE AKTIENGESELLSCHAFT reassignment BAYER CROPSCIENCE AKTIENGESELLSCHAFT NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: BAYER INTELLECTUAL PROPERTY GMBH
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the invention relates to the technical field of the chemical synthesis of biologically active compounds, preferably for intermediates for the synthesis of fine chemicals and active ingredients from pharmacy and/or agriculture.
  • One class of compounds which can be prepared in this way is, for example, optionally substituted 3-alkylthioindol-2-ones (3-(alkylsulfanyl)-1,3-dihydro-2H-indol-2-ones), which can in turn be converted to optionally substituted 2-oxindoles (1,3-dihydro-2H-indol-2-ones).
  • Optionally substituted oxindoles and their precursors, such as optionally substituted 3-alkylthioindol-2-ones are versatile intermediates for active ingredient syntheses (Bioorg. Med. Chem. Lett. 2006, 16, 2109; JP 2008-101014; WO 96/41799 A1). Further uses as precursors to pharmaceutical compounds are described in: US 2005/0090541 A1, EP 636608 A, U.S. Pat. No. 4,690,943A.
  • the chlorinating agent of choice is the unstable and explosive tert-butyl hypochlorite since the by-product of the chlorination then gives the neutral tert-butyl alcohol.
  • SO 2 Cl 2 sulfuryl chloride
  • a second, non-nucleophilic base such as “proton sponge”
  • the compounds (4) described by this process can only be prepared because of the mechanism of the reaction via the compounds (2).
  • a base (C) is required for the rearrangement to the compounds (4).
  • an additional base to the aniline (compounds of formula Q) such as “proton sponge” or triethylamine is specified for this purpose.
  • the additional base used in these processes must inevitably be recovered in the case of syntheses on an industrial scale and be separated from the unreacted compounds of formula Q in order to be able to use the reisolated compounds of formula Q again as starting materials.
  • the N-chloroaniline is able to convert to an aromatic chlorinated in the ring, and also form other oxidation products (dimers). It is therefore not surprising that the acetanilide which is significantly less electron-rich and thus significantly less chlorination-reactive to the ring only forms ring chlorinations with tert-butyl hypochlorite at 0° C. (Lengyel et. al. Synth. Comm., 1998, 28 (10), 1891-1896).
  • the sulfonium intermediates (2) or (3) can eliminate in the presence of bases and form the reactive by-product (5), which would condense, e.g. with an aniline, as a result of which the secondary component (6) is produced irreversibly (see scheme 4). This corresponds to the so-called Pummerer oxidation of the R2-CH—R3 radical.
  • the compounds (4) prepared in this way should preferably also permit further processing to oxindoles (1,3-dihydro-2H-indol-2-ones), which may likewise be intermediates for the synthesis of fine chemicals and active ingredients from pharmacy and/or agriculture.
  • the invention provides a process for the preparation of compounds of formula (4):
  • the thioether (compound of formula W) used in the process according to the invention has the following structure:
  • the aniline (compound of formula Q) used in the process according to the invention has the following structure:
  • Suitable chlorinating agents are all chlorinating agents known to the person skilled in the art for this purpose, such as trichloroisocyanuric acid, tert-butyl hypochlorite and sulfuryl chloride. Preference is given to chlorinating agents such as sulfuryl chloride (SO 2 Cl 2 ), which surprisingly generate, in contrast to the opinion in the literature, HCl without a second, non-nucleophilic base having to be used.
  • reaction in the process according to the invention can be carried out with various solvents.
  • nonpolar organic solvents such as chloroalkanes (for example dichloromethane and dichloroethane), aromatics (for example benzene, toluene, xylene), haloaromatics (for example chlorobenzene, dichlorobenzene), substituted aromatics (for example benzotrifluoride, chlorobenzotrifluoride, chlorotoluene, chloroxylene) alone or as mixtures with one another or as mixtures with alkanes and cycloalkanes.
  • chloroalkanes for example dichloromethane and dichloroethane
  • aromatics for example benzene, toluene, xylene
  • haloaromatics for example chlorobenzene, dichlorobenzene
  • substituted aromatics for example benzotrifluoride, chlorobenzotrifluoride, chlorotoluene, chloroxylene
  • the reaction in the process according to the invention can preferably be carried out in an ester solvent, such as, for example, C1-C6 alkyl acetate (for example methyl acetate, ethyl acetate, n-propyl acetate, isopropyl acetate, 2-methylprop-1-yl acetate, n-butyl acetate, but-2-yl acetate, pentyl acetates, hexyl acetates and cycloalkyl acetates, C1-C6 alkyl and cycloalkyl propionates, C1-C6 alkyl and cycloalkyl n-butyrates, isobutyrates, pentano
  • C1-C6 alkyl acetate for example methyl acetate, ethyl acetate, n-propyl acetate, isopropyl acetate, 2-methylprop-1-yl acetate, n-buty
  • chlorinating agent is added to a mixture of one equivalent of the thioether (compound of formula W) and an industrially economic excess of the aniline (compound of formula Q) of 2.0 to 5.0 equivalents, preferably 2.0 to 3.0 equivalents, particularly preferably 2.0 to 2.5 equivalents.
  • the chlorinating agent can preferably be prediluted with a solvent or a solvent mixture and can preferably be prechilled.
  • a part amount of the aniline (between 1 and 99% by weight, preferably between 20 and 80% by weight, particularly preferably 30 to 70% by weight, of the total amount of aniline) is added separately from, but simultaneously or partially simultaneously with the chlorinating agent.
  • One particular embodiment of the invention with regard to a simplified (industrial) process course is that, in the process according to the invention for the preparation of compounds of formula (4) it is possible to dispense with the addition of an additional tertiary amine, as a result of which re-use of the unreacted, reisolated aniline (compound of formula Q) is simplified.
  • the invention also provides the process for the preparation of compounds of formulae (7) and (8):
  • mineral acids in particular HCl, in gaseous form or in a solvent, preferably water or alcohol.
  • the acid catalyst used in the process according to the invention is used in amounts customary to the person skilled in the art for this purpose.
  • the invention therefore also provides the compounds of formula (4′), which are obtainable by the above-described process according to the invention and which are novel, as intermediates for the preparation of fine chemicals and active ingredients from pharmacy or agriculture:
  • R1 C2-C6 alkyl, benzyl
  • R4 2-F, 2-Cl
  • R5 H, C1-C4 alkyl.
  • R3 CO 2 -methyl, CO 2 -ethyl
  • R4 2-F, 2-Cl
  • R5 H, methyl, ethyl.
  • the invention also provides end products of formula (7′) which are obtainable by the above-described process according to the invention and which are novel:
  • R1 C2-C6 alkyl, benzyl
  • R4 7-F, 7-Cl
  • R4 7-F, 7-Cl
  • the invention also provides the compounds of formula (8′), which are obtainable by the above-described process according to the invention and which are novel, as intermediates for the preparation of fine chemicals and active ingredients from pharmacy or agriculture:
  • R1 C2-C6 alkyl, benzyl
  • R4 7-F, 7-Cl
  • R5 H, C1-C4 alkyl.
  • R4 7-F, 7-Cl
  • R5 H, methyl.
  • the invention also provides for the use of the novel compounds of formulae (4′), (7′) and (8′) obtained according to the invention and prepared by the above-described process according to the invention for the preparation of further processing products, where the group SR1 is replaced by hydrogen via a desulfonation process known to the person skilled in the art.
  • radicals alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino and alkylthio, and also the corresponding unsaturated and/or substituted radicals in the carbon backbone may in each case be straight-chain or branched.
  • the lower carbon backbones e.g. having 1 to 6 carbon atoms, or in the case of unsaturated groups having 2 to 6 carbon atoms, are preferred.
  • Alkyl radicals, including in the composite meaning such as alkoxy, haloalkyl etc., are e.g.
  • Cycloalkyl is a carbocyclic, saturated ring system having preferably 3 to 8 carbon atoms, e.g. cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • Halogen is, for example, fluorine, chlorine, bromine or iodine.
  • Haloalkyl is alkyl partially or completely substituted by halogen, preferably by fluorine, chlorine and/or bromine, in particular by fluorine and/or chlorine, e.g. monohaloalkyl, perhaloalkyl, CF 3 , CHF 2 , CH 2 F, CF 3 CF 2 , CH 2 FCHCl, CCl 3 , CHCl 2 , CH 2 CH 2 Cl;
  • haloalkoxy is e.g. OCF 3 , OCHF 2 , OCH 2 F, CF 3 CF 2 O, OCH 2 CF 3 and OCH 2 CH 2 Cl; the same applies for other radicals substituted by halogen.
  • Aryl is a mono-, bi- or polycyclic aromatic system, for example phenyl, naphthyl, tetrahydronaphthyl, indenyl, indanyl, pentalenyl, fluorenyl and the like, preferably phenyl.
  • a heterocyclic radical or ring may be saturated, unsaturated or heteroaromatic; it contains preferably one or more, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O and S; it is preferably an aliphatic heterocyclyl radical having 3 to 7 ring atoms or a heteroaromatic radical having 5 or 6 ring atoms.
  • the heterocyclic radical may be e.g. a heteroaromatic radical or ring (heteroaryl), such as e.g.
  • a mono-, bi- or polycyclic aromatic system in which at least 1 ring contains one or more heteroatoms for example pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, thienyl, thiazolyl, thiadiazolyl, oxazolyl, isoxazolyl, furyl, pyrrolyl, pyrazolyl and imidazolyl, or is a partially or completely hydrogenated radical such as oxiranyl, pyrrolidyl, piperidyl, piperazinyl, dioxolanyl, oxazolinyl, isoxazolinyl, oxazolidinyl, isoxazolidinyl, morpholinyl, tetrahydrofuryl.
  • heteroatoms for example pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, tria
  • Suitable substituents for a substituted heterocyclic radical are the substituents given below, additionally also oxo.
  • the oxo group can also occur on the heteroring atoms, which can exist in various oxidation states, e.g. in the case of N and S.
  • Substituted radicals such as a substituted alkyl, aryl, phenyl, benzyl, heterocyclyl and heteroaryl radical, are, for example, a substituted radical derived from the unsubstituted basic body, where the substituents are, for example, one or more, preferably 1, 2 or 3, radicals from the group halogen, alkoxy, haloalkoxy, alkylthio, hydroxy, amino, nitro, carboxy, cyano, azido, alkoxycarbonyl, alkylcarbonyl, formyl, carbamoyl, mono- and dialkylaminocarbonyl, sulfamoyl, mono- and dialkylaminosulfonyl, substituted amino, such as acylamino, mono- and dialkylamino, and alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfony
  • radicals with carbon atoms preference is given to those having 1 to 4 carbon atoms, in particular 1 or 2 carbon atoms.
  • substituents from the group consisting of halogen, e.g. fluorine and chlorine, (C1-C4)alkyl, preferably methyl or ethyl, (C1-C4)haloalkyl, preferably trifluoromethyl, (C1-C4)alkoxy, preferably methoxy or ethoxy, (C1-C4)haloalkoxy, nitro and cyano.
  • substituents methyl and fluorine.
  • the formulae (4′), (7′) and (8′) also include, if applicable, all stereoisomers. Such compounds contain one or more asymmetric carbon atoms which are not stated separately in the general formulae.
  • the possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, can be obtained by customary methods from mixtures of the stereoisomers or else can be prepared by stereoselective reactions in combination with the use of stereochemically pure starting substances.
  • the process according to the invention for obtaining compounds of formula (4) is carried out, for example, by initially introducing aniline (compound of formula Q) and thioether (compound of formula W) in the solvent and, preferably under protective gas, cooling. A mixture of chlorinating agent and solvent is added dropwise to this stirred solution. The reaction is then heated and diluted with an aqueous acid. The phases are separated and the organic phase is washed with an aqueous acid. The organic phase is then dried and if the compound of formula (4) is a solid, concentrated in vacuo, and possibly an antisolvent is added and the mixture is stirred for several hours. The solid (compound of formula (4)) is filtered off and washed with the antisolvent or solvent mixture. If the compound of formula (4) is an oil, the organic phase is concentrated in vacuo.
  • the process according to the invention for obtaining compounds of formulae (7) and (8) is carried out, for example, by initially introducing aniline (compound of formula Q) and thioether (compound of formula W) in the solvent and, preferably under protective gas, cooling. A mixture of chlorinating agent and solvent is added dropwise to this stirred solution. The reaction is then heated and diluted with an aqueous acid. The phases are separated and the organic phase is washed with an aqueous acid. The organic phase is then, possibly for compounds of formula (7) and preferably for compounds of formula (8), admixed with an acid catalyst and stirred for several hours. 90% of the solvent is then removed in vacuo and an antisolvent is added and the mixture is stirred for several hours. The solid (compound of formula (7) or (8)) is filtered off and washed with the antisolvent or solvent mixture.
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (77 ml) and cooled to ⁇ 30° C. under protective gas.
  • a solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added dropwise to this stirred solution in 30 minutes.
  • the reaction mixture was warmed to 10° C. and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1 ⁇ 110 ml).
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (77 ml) and cooled to ⁇ 50° C. under protective gas.
  • a solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added dropwise to this stirred solution in 30 minutes at an internal temperature of from ⁇ 53 to ⁇ 48° C.
  • the reaction mixture was warmed to 10° C., diluted with 0.4N hydrochloric acid (110 ml) and afterstirred for 5 min. The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1 ⁇ 110 ml).
  • 2-Fluoroaniline (18.1 g) and methyl methylmercaptoacetate (8.58 g) were initially introduced into n-butyl acetate (80 ml) and cooled to ⁇ 20° C. under protective gas.
  • a solution of sulfuryl chloride (8.77 g) in n-butyl acetate (70 ml) was added dropwise to this stirred solution in 30 minutes at an internal temperature of from ⁇ 25 to ⁇ 18° C.
  • the reaction mixture was warmed to 10° C. over the course of 60 min and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1 ⁇ 110 ml).
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into dichloromethane (77 ml) and cooled to ⁇ 30° C. under protective gas.
  • a solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added to this stirred solution in 30 minutes at an internal temperature of from ⁇ 33 to ⁇ 28° C.
  • the reaction mixture was warmed to 10° C., diluted with 0.4N hydrochloric acid (110 ml) and afterstirred for 5 min. The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1 ⁇ 110 ml).
  • 2-Fluoroaniline (7.73 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (67 ml) and cooled to ⁇ 35° C. under protective gas.
  • a solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was metered into this stirred solution and, in parallel to this, 2-fluoroaniline (10.04 g) in n-butyl acetate (10 ml) was metered directly into the reaction solution in 25 minutes, during which the temperature increased to ⁇ 29° C. After 15 minutes at ⁇ 30° C., the reaction mixture was warmed to 10° C.
  • 2-Fluoroaniline (18.1 g) and 1-(methylsulfanyl)acetone (7.44 g) were initially introduced into n-butyl acetate (80 ml) and cooled to ⁇ 30° C. under protective gas. With stirring, a solution of sulfuryl chloride (8.77 g) in n-butyl acetate (70 ml) was added dropwise over the course of 30 minutes and the mixture was afterstirred for 1.5 hours at an internal temperature of from ⁇ 35 to ⁇ 28° C. The reaction mixture was warmed to 0° C. and the phases were separated.

Abstract

The present invention relates to processes for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses. The invention further relates to a process for the preparation of compounds of formula (4):
Figure US20110118478A1-20110519-C00001
where a mixture of an aniline (compound of formula Q) is reacted with a thioether (compound of formula W):
Figure US20110118478A1-20110519-C00002
in the presence of a chlorinating agent and an organic solvent at a reaction temperature in the range above −65° C.
In a subsequent process, this compound is further reacted in the presence of an acid catalyst to give the indole of formula (7) or the oxindole of formula (8):
Figure US20110118478A1-20110519-C00003

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims priority to EP 09006050.0 filed May 2, 2009, the content of which is incorporated herein by reference in its entirety.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The invention relates to the technical field of the chemical synthesis of biologically active compounds, preferably for intermediates for the synthesis of fine chemicals and active ingredients from pharmacy and/or agriculture.
  • 2. Description of Related Art
  • In principle, the selective exchange of hydrogen on an aromatic system with a substituted carbon atom belongs to one of the fundamental reactions in organic chemistry and is therefore known.
  • One class of compounds which can be prepared in this way is, for example, optionally substituted 3-alkylthioindol-2-ones (3-(alkylsulfanyl)-1,3-dihydro-2H-indol-2-ones), which can in turn be converted to optionally substituted 2-oxindoles (1,3-dihydro-2H-indol-2-ones). Optionally substituted oxindoles and their precursors, such as optionally substituted 3-alkylthioindol-2-ones, are versatile intermediates for active ingredient syntheses (Bioorg. Med. Chem. Lett. 2006, 16, 2109; JP 2008-101014; WO 96/41799 A1). Further uses as precursors to pharmaceutical compounds are described in: US 2005/0090541 A1, EP 636608 A, U.S. Pat. No. 4,690,943A.
  • Most of the described various syntheses of oxindoles use a variation of a Friedel-Crafts reaction (Stolle Synthesis, W. C. Sumpter, Chem. Rev. 1945, 37, 443-449). However, Stolle syntheses can only be used with restrictions since they require strongly acidic conditions and an electron-rich aniline. In addition, however, radical, nitrenium ion and organolithium reactions, and also photochemically dependent methods are also known. However, these are also limited by the type of oxindoles to be prepared, the compatibility of substrates, the reaction conditions, and also by the fact that the aromatic must already have a halogen substituent which is then replaced. (Radical processes: Zard et al., Tetrahedron Lett. 1994, 35, 9553-9556; Zard et al., Tetrahedron Lett. 1994, 35, 1719-1722; Jones et al., Tetrahedron Lett. 1994, 35, 7673-7676; Kikugawa et al., Chem. Letters 1987, 1771-1774; Clark et al., Synthesis 1991, 871-878; Yonemitsu et. al., Chem. Pharm. Bull. 1981, 29, 128-136; see scheme 1).
  • Figure US20110118478A1-20110519-C00004
  • The process by Gassman et al. (Organic Synthesis Coll., vol. 6, 601 and vol. 56, 72), which proceeds from aniline and methyl thioacetate ester via chlorination and treatment with triethylamine at −70° C., appears suitable with regard to feasibility, availability of starting materials, short reaction rate and reproducibility. However, it is also described that good yields can only be achieved if the unstable N-chloro (1) or N-sulfonium (2) intermediates are formed below −65° C., in the normal case at −78° C. (Gassman et. al., J. Am. Chem. Soc., 1974, 96(17), 5508; Gassman et al., J. Am. Chem. Soc., 1974, 96(17), 5512; WO 96/41799 A1; see scheme 2).
  • Figure US20110118478A1-20110519-C00005
  • The chlorinating agent of choice according to the literature is the unstable and explosive tert-butyl hypochlorite since the by-product of the chlorination then gives the neutral tert-butyl alcohol. In the few cases in which sulfuryl chloride (SO2Cl2) has been used, a second, non-nucleophilic base, such as “proton sponge”, has been used (Johnson, J. Org. Chem. 1990, 55, 1374; Warpehoski, Tetrahedron Lett. 1986, 27, 4103). Since both variants are carried out at low temperatures, however, this is not a practicable solution on an industrial scale.
  • Wright et al. (Tetrahedron Lett. 1996, 37, 4631) describe an alternative where the chlorosulfonium intermediate (3) has been prepared from a sulfoxide and oxalyl chloride (see scheme 3). Here, the chlorosulfonium intermediate (3) is likewise unstable. For this reaction, the sulfoxide must first be prepared and isolated. For reasons of stability, the reaction must proceed at −78° C. and, in order to avoid a reaction between aniline and oxalyl chloride, the reaction is carried out in stages.
  • Figure US20110118478A1-20110519-C00006
  • The compounds (4) described by this process (scheme 2 or scheme 3) can only be prepared because of the mechanism of the reaction via the compounds (2). Inevitably here, the use of a base (C) is required for the rearrangement to the compounds (4). In the literature, an additional base to the aniline (compounds of formula Q) such as “proton sponge” or triethylamine is specified for this purpose. The additional base used in these processes must inevitably be recovered in the case of syntheses on an industrial scale and be separated from the unreacted compounds of formula Q in order to be able to use the reisolated compounds of formula Q again as starting materials.
  • The reasons why the reaction is so sensitive to reaction temperatures above −70° C. and why it has always been carried out in stages are manifold.
  • Firstly, the functional groups which participate in the reaction, i.e. the nitrogen atom of the aniline and the sulfur atom of the thioether, occur unchanged both in the product (4) and also in the starting material. Consequently, a selective chlorination during the reaction would not be expected in which the product (4) is formed directly. For this reason, all methods known in the literature use a stepwise reaction.
  • Moreover, at temperatures higher than −65° C., the N-chloroaniline is able to convert to an aromatic chlorinated in the ring, and also form other oxidation products (dimers). It is therefore not surprising that the acetanilide which is significantly less electron-rich and thus significantly less chlorination-reactive to the ring only forms ring chlorinations with tert-butyl hypochlorite at 0° C. (Lengyel et. al. Synth. Comm., 1998, 28 (10), 1891-1896).
  • Furthermore, the sulfonium intermediates (2) or (3) can eliminate in the presence of bases and form the reactive by-product (5), which would condense, e.g. with an aniline, as a result of which the secondary component (6) is produced irreversibly (see scheme 4). This corresponds to the so-called Pummerer oxidation of the R2-CH—R3 radical.
  • Figure US20110118478A1-20110519-C00007
  • It was therefore the object to provide a modified process which permits a preparation, improved compared to the aforementioned processes, of compounds (4) via intermediates (2) (sulfonium salts) on an industrial scale with advantages such as improved overall yield and/or product purity, reduced use of starting materials, omission of further auxiliaries (such as, e.g. a second base) or simplified process course (such as, e.g. reactions at a higher temperature) or use of industrially more suitable solvents (less toxic, better recoverable).
  • The compounds (4) prepared in this way should preferably also permit further processing to oxindoles (1,3-dihydro-2H-indol-2-ones), which may likewise be intermediates for the synthesis of fine chemicals and active ingredients from pharmacy and/or agriculture.
  • SUMMARY OF THE INVENTION
  • Surprisingly, it has now been found that, despite the aforementioned problems, the reaction could be modified in such a way that it can be carried out on an industrially realizable scale.
  • The invention provides a process for the preparation of compounds of formula (4):
  • Figure US20110118478A1-20110519-C00008
      • where
      • R1=C1-C6 alkyl, substituted alkyl, aryl or substituted aryl, preferably C1-C4 alkyl;
      • R2=H, C1-C6 alkyl or substituted alkyl;
      • R3=electron-withdrawing or activating group, such as —CO—R1; —CO—X,
        • where X═OR1, SR1, NR2R2′, where R2′ is defined like R2 and may be identical to or different from R2; R2 and R2′ can form a ring; SO(n′)—R1, where n′=may be 0, 1 or 2; —CN; —NO2, aryl or heteroaryl;
      • R4=F, Cl, Br, I, CF3, CN, NO2, COX;
        • where X═OR1, SR1, NR2R2′, where R2′ is defined like R2 above and may be identical to or different from R2, preferably F or Cl, in particular 2-F;
      • n=1-4, preferably 1-2, in particular 1;
      • R5=H, C1-C6 alkyl or substituted alkyl,
      • which comprises reacting a mixture
      • of an aniline (compound of formula Q):
  • Figure US20110118478A1-20110519-C00009
      • in which the radicals R4, n and R5 are as defined in formula (4),
      • with a thioether (compound of formula W):
  • Figure US20110118478A1-20110519-C00010
  • in which the radicals R1, R2 and R3 are as defined in formula (4),
  • in the presence of a chlorinating agent and an organic solvent at a reaction temperature in the range above −65° C., preferably between −60 and −10° C., in particular between −50 and −20° C., to give the compound of formula (4) via the mechanistically stipulated intermediate of formula (2).
  • DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
  • The selective and clean reaction with good yields resulting therefrom is particularly surprising and stands in contrast to the school of thought according to which it is described that good yields can only be achieved if the unstable N-chloro (1) or N-sulfonium (2) intermediates (see scheme 2) are formed below −65° C., in the normal case at −78° C. (Gassman et. al., J. Am. Chem. Soc., 1974, 96(17), 5508; Gassman et al., J. Am. Chem. Soc., 1974, 96(17), 5512; WO 96/41799 A1).
  • The thioether (compound of formula W) used in the process according to the invention has the following structure:
  • Figure US20110118478A1-20110519-C00011
  • where
    • R1=C1-C6 alkyl, substituted alkyl, aryl or substituted aryl, preferably C1-C4 alkyl;
    • R2=H, C1-C6 alkyl or substituted alkyl;
    • R3=electron-withdrawing or activating group, such as —CO—R1; —CO—X, where X=OR1, SR1, NR2R2′, where R2′ is defined like R2 and may be identical to or different from R2; R2 and R2′ can form a ring; SO(n′)—R1, where n′=may be 0, 1 or 2; —CN; —NO2, aryl or heteroaryl.
  • Wherever reference is made to thioether hereinbelow, the compound given above is intended.
  • The aniline (compound of formula Q) used in the process according to the invention has the following structure:
  • Figure US20110118478A1-20110519-C00012
  • where
    • R4=F, Cl, Br, I, CF3, CN, NO2, COX;
      • where X=OR1, SR1, NR2R2′, where R2′ is defined like R2 above and may be identical to or different from R2, preferably F or Cl, in particular 2-F;
    • n=1-4, preferably 1-2, in particular 1;
    • R5=H, C1-C6 alkyl or substituted alkyl.
  • It is obligatory that a hydrogen atom is present in the ortho position relative to the nitrogen atom of the aniline. The ring can be substituted with one or more substituents R4. Wherever reference is made to aniline hereinbelow, the compound given above is intended.
  • Suitable chlorinating agents are all chlorinating agents known to the person skilled in the art for this purpose, such as trichloroisocyanuric acid, tert-butyl hypochlorite and sulfuryl chloride. Preference is given to chlorinating agents such as sulfuryl chloride (SO2Cl2), which surprisingly generate, in contrast to the opinion in the literature, HCl without a second, non-nucleophilic base having to be used.
  • The reaction in the process according to the invention can be carried out with various solvents.
  • For example, it is possible to use nonpolar organic solvents, such as chloroalkanes (for example dichloromethane and dichloroethane), aromatics (for example benzene, toluene, xylene), haloaromatics (for example chlorobenzene, dichlorobenzene), substituted aromatics (for example benzotrifluoride, chlorobenzotrifluoride, chlorotoluene, chloroxylene) alone or as mixtures with one another or as mixtures with alkanes and cycloalkanes.
  • In addition, however, polar organic solvents are also suitable. This is contrary to the teaching of Gassman (J. Am. Chem. Soc., 1972, 94, 3891), according to which N-chloro derivatives are less stable in polar solvents. For example, the reaction in the process according to the invention can preferably be carried out in an ester solvent, such as, for example, C1-C6 alkyl acetate (for example methyl acetate, ethyl acetate, n-propyl acetate, isopropyl acetate, 2-methylprop-1-yl acetate, n-butyl acetate, but-2-yl acetate, pentyl acetates, hexyl acetates and cycloalkyl acetates, C1-C6 alkyl and cycloalkyl propionates, C1-C6 alkyl and cycloalkyl n-butyrates, isobutyrates, pentanoates and hexanoates and cyclopentanoates and cyclohexanoates) or in mixtures thereof or in a mixture with other solvents. Compared with other solvents, such as e.g. the dichloromethane used in the literature, ester solvents have the advantage that they are industrially more suitable (less toxic, better recoverable).
  • The process according to the invention for the preparation of compounds of formula (4) is based on the fact that the two compounds aniline (compound of formula Q) and thioether (compound of formula W) can be advantageously premixed.
  • The selective and clean reaction resulting therefrom is particularly surprising and stands in contrast to the school of thought according to which Gassman demonstrated that, depending on the substituent, N-chlorination or S-chlorination is optimal for the reaction (Gassman, J. Am. Chem. Soc., 1974, 96(17), 5512). Furthermore, a mixture consisting of aniline and thioether would not be expected to exhibit selectivity during a chlorination, which is why, according to the school of thought hitherto, the process has only been carried out stepwise.
  • For good product yields it has been found that it is advantageous to use up to 1 equivalent, preferably 0.5 to 1.0 equivalent, particularly preferably 0.7 to 1.0 equivalent, especially preferably 0.8 to 0.95 equivalent, of the chlorinating agent. The chlorinating agent is added to a mixture of one equivalent of the thioether (compound of formula W) and an industrially economic excess of the aniline (compound of formula Q) of 2.0 to 5.0 equivalents, preferably 2.0 to 3.0 equivalents, particularly preferably 2.0 to 2.5 equivalents.
  • The chlorinating agent can preferably be prediluted with a solvent or a solvent mixture and can preferably be prechilled.
  • It is a particular embodiment of the invention that, for good product yields, also a part amount of the aniline (between 1 and 99% by weight, preferably between 20 and 80% by weight, particularly preferably 30 to 70% by weight, of the total amount of aniline) is added separately from, but simultaneously or partially simultaneously with the chlorinating agent.
  • One particular embodiment of the invention with regard to a simplified (industrial) process course is that, in the process according to the invention for the preparation of compounds of formula (4) it is possible to dispense with the addition of an additional tertiary amine, as a result of which re-use of the unreacted, reisolated aniline (compound of formula Q) is simplified.
  • Thus, it has been found that an excess of the surprisingly low-electron anilines acts as a mild base during the formation of product of formula (4). This is surprising compared with the standard Gassman reaction which uses the addition of an additional tertiary amine (cf. schemes 2 and 3: C=tertiary amine base, e.g.: triethylamine). The aniline is obviously able to catalyze the rearrangement to the product of formula (4) and therefore also to eliminate HCl from a chlorosulfonium intermediate of formula (3), which would only lead to secondary reactions. Nevertheless and precisely because of this, it is very surprising that the reaction can be carried out in this way. At the same time, the omission of an additional tertiary amine in the process according to the invention is advantageous since it is possible to dispense with a subsequent complex separation of recovered aniline and tertiary amine.
  • The invention also provides the process for the preparation of compounds of formulae (7) and (8):
  • Figure US20110118478A1-20110519-C00013
      • in which
      • R1=C1-C6 alkyl, substituted alkyl, aryl or substituted aryl, preferably C1-C4 alkyl;
      • R2=H, C1-C6 alkyl or substituted alkyl;
      • R4=F, Cl, Br, I, CF3, CN, NO2, COX;
        • where X=OR1, SR1, NR2R2′, where R2′ is defined like R2 above and may be identical to or different from R2, preferably F or Cl, in particular 2-F;
      • n=1-4, preferably 1-2, in particular 1;
      • R5=H, C1-C6 alkyl or substituted alkyl;
      • R6=C1-C6 alkyl or substituted alkyl, preferably C1-C4 alkyl or OH;
      • where compounds of formula (4):
  • Figure US20110118478A1-20110519-C00014
  • with the aforementioned definitions of the radicals R1, R2, R4 and R5 and where R3 is an electron-withdrawing or activating group, such as —CO—R1; —CO—X, where X═OR1, SR1, NR2R2′, where R2′ is defined like R2 and may be identical to or different from R2; R2 and R2′ can form a ring; SO(n′)—R1, where n′ may be 0, 1 or 2; —CN; —NO2, aryl or heteroaryl;
  • prepared by the above-described process according to the invention for the preparation of compounds of formula (4), are reacted without isolation of the compounds of formula (4), optionally in the presence of an acid catalyst, to give the indole of formula (7) or the oxindole of formula (8).
  • In the case of R3=CO—R1, the indole of formula (7) is obtained, whereas in the case of R3=COX, the oxindole of formula (8) or the indole of formula (7) where R6=OH is obtained. Consequently, within the context of the present invention, these specific indoles are therefore also encompassed by the term “oxindole”.
  • For the acid catalyst in the process according to the invention, it is possible to use mineral or organic acids such as H+X, where X=F, Cl, Br, I, HSO4 , BF4 , H2PO4 , SO4 2−, HPO4 2−, PO4 3−, R′SO3 , R″HPO3 , R′″PO3 2−, R″″CO2 , or mixtures thereof. Preference is given to using mineral acids, in particular HCl, in gaseous form or in a solvent, preferably water or alcohol. The acid catalyst used in the process according to the invention is used in amounts customary to the person skilled in the art for this purpose.
  • Based on the standard process by Gassman et. al. (J. Am. Chem. Soc., 1974, 96(17), 5508), a number of oxindoles or ortho-substituted anilines have been synthesized. Thus, e.g. on the route of the synthesis of a 7-fluoroisatin, the intermediate 7-fluoro-3-methylthiooxindole (7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole) was synthesized (Wierenga et al., Tetrahedron Lett. 1983, 24, 2437). One example of a 7-fluoro-3-methylthio-4-nitrooxindole prepared by the Gassman process using proton sponge and triethylamine can be found in Tetrahedron Lett. 2005, 46, 4613.
  • The invention therefore also provides the compounds of formula (4′), which are obtainable by the above-described process according to the invention and which are novel, as intermediates for the preparation of fine chemicals and active ingredients from pharmacy or agriculture:
  • Figure US20110118478A1-20110519-C00015
  • where
    R1=C2-C6 alkyl, benzyl;
  • R2=H;
  • R3=CO2R″, where R″=may be C1-C6 alkyl, benzyl ester;
  • R4=2-F, 2-Cl;
  • R5=H, C1-C4 alkyl.
  • Preference is given to compounds of formula (4′), where
  • R1=ethyl;
  • R2=H;
  • R3=CO2-methyl, CO2-ethyl;
  • R4=2-F, 2-Cl;
  • R5=H, methyl, ethyl.
  • The invention also provides end products of formula (7′) which are obtainable by the above-described process according to the invention and which are novel:
  • Figure US20110118478A1-20110519-C00016
  • where
    R1=C2-C6 alkyl, benzyl;
  • R4=7-F, 7-Cl;
  • R5=H, C1-C4 alkyl;
    R6=C1-C6 alkyl.
  • Preference is given to compounds of formula (7′), where
  • R1=ethyl;
  • R4=7-F, 7-Cl;
  • R5=H, methyl;
    R6=C1-C6 alkyl.
  • The invention also provides the compounds of formula (8′), which are obtainable by the above-described process according to the invention and which are novel, as intermediates for the preparation of fine chemicals and active ingredients from pharmacy or agriculture:
  • Figure US20110118478A1-20110519-C00017
  • where
    R1=C2-C6 alkyl, benzyl;
  • R2=H; R4=7-F, 7-Cl;
  • R5=H, C1-C4 alkyl.
  • Preference is given to compounds of formula (8′) where
  • R1=ethyl;
  • R2=H; R4=7-F, 7-Cl;
  • R5=H, methyl.
  • The invention also provides for the use of the novel compounds of formulae (4′), (7′) and (8′) obtained according to the invention and prepared by the above-described process according to the invention for the preparation of further processing products, where the group SR1 is replaced by hydrogen via a desulfonation process known to the person skilled in the art.
  • In connection with the chemical terms used in this description, the definitions customary for the person skilled in the art apply unless specifically defined otherwise. The radicals alkyl, alkoxy, haloalkyl, haloalkoxy, alkylamino and alkylthio, and also the corresponding unsaturated and/or substituted radicals in the carbon backbone may in each case be straight-chain or branched. Unless specifically stated, in these radicals, the lower carbon backbones, e.g. having 1 to 6 carbon atoms, or in the case of unsaturated groups having 2 to 6 carbon atoms, are preferred. Alkyl radicals, including in the composite meaning such as alkoxy, haloalkyl etc., are e.g. methyl, ethyl, n-propyl or isopropyl, n-, iso-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, isohexyl and 1,3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1,4-dimethylpentyl.
  • Cycloalkyl is a carbocyclic, saturated ring system having preferably 3 to 8 carbon atoms, e.g. cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • Halogen is, for example, fluorine, chlorine, bromine or iodine. Haloalkyl is alkyl partially or completely substituted by halogen, preferably by fluorine, chlorine and/or bromine, in particular by fluorine and/or chlorine, e.g. monohaloalkyl, perhaloalkyl, CF3, CHF2, CH2F, CF3CF2, CH2FCHCl, CCl3, CHCl2, CH2CH2Cl; haloalkoxy is e.g. OCF3, OCHF2, OCH2F, CF3CF2O, OCH2CF3 and OCH2CH2Cl; the same applies for other radicals substituted by halogen.
  • Aryl is a mono-, bi- or polycyclic aromatic system, for example phenyl, naphthyl, tetrahydronaphthyl, indenyl, indanyl, pentalenyl, fluorenyl and the like, preferably phenyl.
  • A heterocyclic radical or ring (heterocyclyl) may be saturated, unsaturated or heteroaromatic; it contains preferably one or more, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O and S; it is preferably an aliphatic heterocyclyl radical having 3 to 7 ring atoms or a heteroaromatic radical having 5 or 6 ring atoms. The heterocyclic radical may be e.g. a heteroaromatic radical or ring (heteroaryl), such as e.g. a mono-, bi- or polycyclic aromatic system in which at least 1 ring contains one or more heteroatoms, for example pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, thienyl, thiazolyl, thiadiazolyl, oxazolyl, isoxazolyl, furyl, pyrrolyl, pyrazolyl and imidazolyl, or is a partially or completely hydrogenated radical such as oxiranyl, pyrrolidyl, piperidyl, piperazinyl, dioxolanyl, oxazolinyl, isoxazolinyl, oxazolidinyl, isoxazolidinyl, morpholinyl, tetrahydrofuryl. Suitable substituents for a substituted heterocyclic radical are the substituents given below, additionally also oxo. The oxo group can also occur on the heteroring atoms, which can exist in various oxidation states, e.g. in the case of N and S.
  • Substituted radicals, such as a substituted alkyl, aryl, phenyl, benzyl, heterocyclyl and heteroaryl radical, are, for example, a substituted radical derived from the unsubstituted basic body, where the substituents are, for example, one or more, preferably 1, 2 or 3, radicals from the group halogen, alkoxy, haloalkoxy, alkylthio, hydroxy, amino, nitro, carboxy, cyano, azido, alkoxycarbonyl, alkylcarbonyl, formyl, carbamoyl, mono- and dialkylaminocarbonyl, sulfamoyl, mono- and dialkylaminosulfonyl, substituted amino, such as acylamino, mono- and dialkylamino, and alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl and, in the case of cyclic radicals, also alkyl and haloalkyl; in the term “substituted radicals”, such as substituted alkyl etc., in addition to the specified saturated hydrocarbon-containing radicals, corresponding unsaturated aliphatic and aromatic radicals, such as optionally substituted phenyl, phenoxy etc., are included as substituents. For radicals with carbon atoms, preference is given to those having 1 to 4 carbon atoms, in particular 1 or 2 carbon atoms. Preference is generally given to substituents from the group consisting of halogen, e.g. fluorine and chlorine, (C1-C4)alkyl, preferably methyl or ethyl, (C1-C4)haloalkyl, preferably trifluoromethyl, (C1-C4)alkoxy, preferably methoxy or ethoxy, (C1-C4)haloalkoxy, nitro and cyano. Particular preference is given here to the substituents methyl and fluorine.
  • The formulae (4′), (7′) and (8′) also include, if applicable, all stereoisomers. Such compounds contain one or more asymmetric carbon atoms which are not stated separately in the general formulae. The possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, can be obtained by customary methods from mixtures of the stereoisomers or else can be prepared by stereoselective reactions in combination with the use of stereochemically pure starting substances.
  • The compounds of formulae Q and W to be used according to the invention are known or can be prepared analogously to generally known processes.
  • The process according to the invention for obtaining compounds of formula (4) is carried out, for example, by initially introducing aniline (compound of formula Q) and thioether (compound of formula W) in the solvent and, preferably under protective gas, cooling. A mixture of chlorinating agent and solvent is added dropwise to this stirred solution. The reaction is then heated and diluted with an aqueous acid. The phases are separated and the organic phase is washed with an aqueous acid. The organic phase is then dried and if the compound of formula (4) is a solid, concentrated in vacuo, and possibly an antisolvent is added and the mixture is stirred for several hours. The solid (compound of formula (4)) is filtered off and washed with the antisolvent or solvent mixture. If the compound of formula (4) is an oil, the organic phase is concentrated in vacuo.
  • The process according to the invention for obtaining compounds of formulae (7) and (8) is carried out, for example, by initially introducing aniline (compound of formula Q) and thioether (compound of formula W) in the solvent and, preferably under protective gas, cooling. A mixture of chlorinating agent and solvent is added dropwise to this stirred solution. The reaction is then heated and diluted with an aqueous acid. The phases are separated and the organic phase is washed with an aqueous acid. The organic phase is then, possibly for compounds of formula (7) and preferably for compounds of formula (8), admixed with an acid catalyst and stirred for several hours. 90% of the solvent is then removed in vacuo and an antisolvent is added and the mixture is stirred for several hours. The solid (compound of formula (7) or (8)) is filtered off and washed with the antisolvent or solvent mixture.
  • The examples below illustrate the process according to the invention in more detail without limiting the process according to the invention thereto. In the examples below, quantitative data refer to the weight, unless specifically defined otherwise (in the description, % by wt.=percent by weight was used analogously for this). For measurement units, physical parameters and the like, customary abbreviations are used, for example h=hour(s), m.p.=melting point, l=liter, ml=milliliter, g=gram, min=minute(s), in vacuo=under reduced pressure, of theory=percent yield according to theory.
  • Examples Synthesis Example 1
  • 2-Chloroaniline (20.4 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into chlorobenzene (77 ml) and cooled to −30° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in chlorobenzene (67 ml) was added dropwise to this stirred solution in 30 minutes. The reaction mixture was warmed to −5° C. and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (4×110 ml). The organic phase was then admixed with 10% strength HCl in MeOH (2 ml) and stirred for 16 hours. 90% of the solvent was removed in vacuo, heptane (120 ml) was added and the mixture was stirred for 4 hours. The solid was filtered off and washed with heptane (2×50 ml). This gives 7-chloro-3-methylthiooxindole (9.36 g, 70% of theory). m.p.: 167-170° C.
  • Synthesis Example 2
  • 2-Chloroaniline (20.4 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into chlorobenzene (77 ml) and cooled to −30° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in chlorobenzene (67 ml) was added dropwise to this stirred solution in 30 minutes. The reaction mixture was warmed to −5° C. and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (4×110 ml) and water (50 ml) and dried over sodium sulfate. The organic phase was filtered and distilled in vacuo. This gives methyl (2-amino-3-chlorophenyl)(methylthio)acetate as brown-red oil (10.9 g, 71% of theory).
  • Synthesis Example 3
  • 4-Chloroaniline (20.4 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (77 ml) and cooled to −30° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added dropwise to this stirred solution in 30 minutes. The reaction mixture was warmed to 10° C. and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (2×110 ml). The organic phase was then admixed with 10% strength HCl in MeOH (2 ml) and stirred for 16 hours. 90% of the solvent was removed in vacuo, heptane (120 ml) was added and the mixture was stirred for 4 hours. The solid was filtered off and washed with heptane (2×50 ml). This gives 5-chloro-3-methylthiooxindole (7.89 g, 59% of theory). m.p.: 154-157° C.
  • Synthesis Example 4
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (77 ml) and cooled to −30° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added dropwise to this stirred solution in 30 minutes. The reaction mixture was warmed to 10° C. and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1×110 ml). The organic phase was then admixed with 10% strength HCl in MeOH (2 ml) and stirred for 16 hours. 90% of the solvent was removed in vacuo, heptane (120 ml) was added and the mixture was stirred for 4 hours. The solid was filtered off and washed with heptane (2×50 ml). This gives 7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole (9.17 g, 72% of theory). m.p.: 156-159° C.
  • Synthesis Example 5
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (77 ml) and cooled to −30° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added dropwise to this stirred solution in 30 minutes. The reaction mixture was warmed to 10° C. and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1×110 ml) and water (50 ml) and dried over sodium sulfate. The organic phase was filtered and distilled in vacuo. This gives methyl (2-amino-3-fluorophenyl)(methylthio)acetate as brown oil (12.5 g, 73% of theory).
  • Synthesis Example 6
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (77 ml) and cooled to −50° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added dropwise to this stirred solution in 30 minutes at an internal temperature of from −53 to −48° C. The reaction mixture was warmed to 10° C., diluted with 0.4N hydrochloric acid (110 ml) and afterstirred for 5 min. The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1×110 ml). The organic phase was admixed with conc. HCl (0.2 ml). The reaction mixture was stirred for 24 hours, admixed once again with conc. HCl (0.05 ml) and left to stand for 16 hours at 4° C. Approximately 90% of the solvent was removed in vacuo, heptane (120 ml) was added and the mixture was stirred for 5 hours. The solid was filtered off, washed with heptane (2×50 ml) and dried. This gives 7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole (8.71 g, 63% of theory). LCMS: M+H=198 (100%). The 1H-NMR is in agreement with that described in synthesis example 7.
  • Synthesis Example 7
  • 2-Fluoroaniline (18.1 g) and methyl methylmercaptoacetate (8.58 g) were initially introduced into n-butyl acetate (80 ml) and cooled to −20° C. under protective gas. A solution of sulfuryl chloride (8.77 g) in n-butyl acetate (70 ml) was added dropwise to this stirred solution in 30 minutes at an internal temperature of from −25 to −18° C. The reaction mixture was warmed to 10° C. over the course of 60 min and diluted with 0.4N hydrochloric acid (110 ml). The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1×110 ml). The organic phase was then admixed with conc. hydrochloric acid (0.5 ml) and MeOH (2 ml) and stirred for 16 hours. Approximately 90% of the solvent was removed in vacuo, n-heptane (120 ml) was added and the mixture was stirred for 3 hours. The solid was filtered off and washed with heptane. This gives 7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole (7.85 g, 55% of theory). 1H-NMR (CDCl3): d=2.06 (s, 3H), 4.32 (s, 1H), 7.02-7.05 (m, 2H), 7.17-7.19 (m, 1H), 8.3 (s, broad, 1H).
  • Synthesis Example 8
  • 2-Fluoroaniline (17.8 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into dichloromethane (77 ml) and cooled to −30° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was added to this stirred solution in 30 minutes at an internal temperature of from −33 to −28° C. The reaction mixture was warmed to 10° C., diluted with 0.4N hydrochloric acid (110 ml) and afterstirred for 5 min. The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1×110 ml). The organic phase was then admixed with conc. HCl (0.2 ml). The reaction mixture was stirred for 16 hours, admixed with conc. HCl (0.05 ml), stirred for 7 hours, admixed once again with conc. HCl (0.05 ml) and afterstirred for 16 hours. Approximately 90% of the solvent was removed in vacuo, heptane (110 ml) was added and the mixture was stirred for 5 hours. The solid was filtered off, washed with heptane (2×50 ml) and dried. This gives 7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole (5.84 g, 42% of theory). LCMS and 1H-NMR are in agreement with those described in synthesis examples 6 and 7.
  • Synthesis Example 9
  • 2-Fluoroaniline (7.73 g) and methyl methylmercaptoacetate (8.36 g) were initially introduced into n-butyl acetate (67 ml) and cooled to −35° C. under protective gas. A solution of sulfuryl chloride (8.45 g) in n-butyl acetate (67 ml) was metered into this stirred solution and, in parallel to this, 2-fluoroaniline (10.04 g) in n-butyl acetate (10 ml) was metered directly into the reaction solution in 25 minutes, during which the temperature increased to −29° C. After 15 minutes at −30° C., the reaction mixture was warmed to 10° C. and 0.4N hydrochloric acid (110 ml) was added dropwise. The phases were separated and the organic phase was washed with 0.4N hydrochloric acid (1×110 ml). The organic phase was admixed with 10% strength HCl in MeOH (1.9 ml) and stirred for 16 hours. 95% of the solvent was removed in vacuo, heptane (120 ml) was added and the reaction mixture was stirred for 3 hours. The solid was filtered off and washed with heptane (2×50 ml). This gives 7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole (8.87 g, 70.0% of theory).
  • Synthesis Example 10
  • 2-Fluoroaniline (18.1 g) and 1-(methylsulfanyl)acetone (7.44 g) were initially introduced into n-butyl acetate (80 ml) and cooled to −30° C. under protective gas. With stirring, a solution of sulfuryl chloride (8.77 g) in n-butyl acetate (70 ml) was added dropwise over the course of 30 minutes and the mixture was afterstirred for 1.5 hours at an internal temperature of from −35 to −28° C. The reaction mixture was warmed to 0° C. and the phases were separated. The organic phase was extracted with 0.5N hydrochloric acid (2×80 ml) and water (40 ml), dried with a small amount of sodium sulfate and concentrated by evaporation in vacuo. The residue is admixed three times with ethyl acetate and concentrated by evaporation. This gives 7-fluoro-2-methyl-3-(methylsulfanyl)-1H-indole as brown oil (9.67 g, 59% of theory). 1H-NMR (CDCl3): d=2.26 (s, 3H), 2.55 (s, 3H), 6.87 (dd, 1H), 7.03-7.08 (m, 1H), 7.43 (d, 1H), 8.24 (s, broad, 1H). LCMS: M+H=196.

Claims (12)

1. A process for the preparation of a compound of formula (4),
Figure US20110118478A1-20110519-C00018
in which
R1=C1-C6 alkyl, substituted alkyl, aryl or substituted aryl;
R2=H, C1-C6 alkyl or substituted alkyl;
R3=electron-withdrawing or activating group optionally selected from the group consisting of —CO—R1 and —CO—X, where X═OR1, SR1, NR2R2′, where R2′ is defined like R2 and may be identical to or different from R2; R2 and R2′ can form a ring; SO(n′)-R1, where n′=may be 0, 1 or 2; —CN; —NO2, aryl or heteroaryl;
R4=F, Cl, Br, I, CF3, CN, NO2, COX;
where X=OR1, SR1, NR2R2′, where R2′ is defined like R2 above and may be identical to or different from R2,
n=1-4, preferably 1-2,
R5=H, C1-C6 alkyl or substituted alkyl,
which comprises reacting a mixture
of an aniline (compound of formula Q):
Figure US20110118478A1-20110519-C00019
in which the radicals R4, n and R5 are as defined in formula (4),
with a thioether (compound of formula W):
Figure US20110118478A1-20110519-C00020
in which the radicals R1, R2 and R3 are as defined in formula (4),
in the presence of a chlorinating agent and an organic solvent at a reaction temperature in the range between −60 and −10° C., to give the compound of formula (4).
2. The process as claimed in claim 1, wherein the reaction is carried out in the industrially more suitable ester solvents, optionally selected from the group consisting of C1-C6 alkyl acetates which can optionally comprise methyl acetate, ethyl acetate, n-propyl acetate, isopropyl acetate, 2-methylprop-1-yl acetate, n-butyl acetate, but-2-yl acetate, pentyl acetates, hexyl acetates and cycloalkyl acetates, C1-C6 alkyl and cycloalkyl propionates, C1-C6 alkyl and cycloalkyl n-butyrates, isobutyrates, pentanoates and hexanoates and cyclopentanoates and cyclohexanoates, or in mixtures thereof or in a mixture with other solvents.
3. The process as claimed in claim 1, wherein, for good product yields, up to 1 equivalent of the chlorinating agent is added to a mixture of one equivalent of the thioether (compound of formula W) and 2.0 to 5.0 equivalents of aniline (compound of formula Q).
4. The process as claimed in claim 1, wherein, for good product yields, a part amount of the aniline from 1 to 99% by weight of the total amount of aniline is added separately from, but simultaneously or partially simultaneously with the chlorinating agent.
5. The process as claimed in claim 1, wherein, with regard to a simplified process course, the addition of an additional tertiary amine is dispensed with.
6. A process for the preparation of compounds of formulae (7) and (8):
Figure US20110118478A1-20110519-C00021
in which
R1=C1-C6 alkyl, substituted alkyl, aryl or substituted aryl,
R2=H, C1-C6 alkyl or substituted alkyl;
R4=F, Cl, Br, I, CF3, CN, NO2, COX;
where X═OR1, SR1, NR2R2′, where R2′ is defined like R2 above and may be identical to or different from R2,
n=1-4,
R5=H, C1-C6 alkyl or substituted alkyl;
R6=C1-C6 alkyl or substituted alkyl, preferably C1-C4 alkyl or OH;
where compounds of formula (4):
Figure US20110118478A1-20110519-C00022
with the aforementioned definitions of the radicals R1, R2, R4, n and R5 and where R3 is an electron-withdrawing or activating group, such as —CO—R1; —CO—X, where X═OR1, SR1, NR2R2′, where R2′ is defined like R2 and may be identical to or different from R2; R2 and R2′ can form a ring; SO(n′)-R1, where n′ may be 0, 1 or 2; —CN; —NO2, aryl or heteroaryl;
prepared by a process as claimed in claim 1;
are reacted without isolation of the compounds of formula (4), optionally in the presence of an acid catalyst, to give the indole of formula (7) or the oxindole of formula (8).
7. A compound of formula (4′)
Figure US20110118478A1-20110519-C00023
where
R1=C2-C6 alkyl, benzyl;
R2=H;
R3=CO2R″, where R″=may be C1-C6 alkyl, benzyl ester;
R4=2-F, 2-Cl;
R5=H, C1-C4 alkyl;
as intermediate for the preparation of a fine chemical and/or active ingredient from pharmacy or agriculture.
8. A compound of formula (7′)
Figure US20110118478A1-20110519-C00024
where
R1=C2-C6 alkyl, benzyl;
R4=7-F, 7-Cl;
R5=H, C1-C4 alkyl;
R6=C1-C6 alkyl;
as intermediate for the preparation of a fine chemical and/or active ingredient from pharmacy or agriculture.
9. A compound of formula (8′)
Figure US20110118478A1-20110519-C00025
where
R1=C2-C6 alkyl, benzyl;
R2=H;
R4=7-F, 7-Cl;
R5=H, C1-C4 alkyl;
as intermediate for the preparation of a fine chemical and/or active ingredient from pharmacy or agriculture.
10. A method for preparation of a processing product wherein an SR1 group is replaced by hydrogen via a desulfonation process, said method comprising using a compound as claimed in claim 7.
11. A method for preparation of a processing product wherein an SR1 group is replaced by hydrogen via a desulfonation process, said method comprising using a compound as claimed in claim 8.
12. A method for preparation of a processing product wherein an SR1 group is replaced by hydrogen via a desulfonation process, said method comprising using a compound as claimed in claim 9.
US12/769,302 2009-05-02 2010-04-28 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses Active 2030-08-01 US8492590B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/915,898 US9242934B2 (en) 2009-05-02 2013-06-12 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09006050 2009-05-02
EP09006050.0 2009-05-02
EP09006050A EP2246326A1 (en) 2009-05-02 2009-05-02 Method for producing oxindoles and ortho-substituted anilines and their use as intermediate products for syntheses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/915,898 Division US9242934B2 (en) 2009-05-02 2013-06-12 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses

Publications (2)

Publication Number Publication Date
US20110118478A1 true US20110118478A1 (en) 2011-05-19
US8492590B2 US8492590B2 (en) 2013-07-23

Family

ID=41050783

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/769,302 Active 2030-08-01 US8492590B2 (en) 2009-05-02 2010-04-28 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses
US13/915,898 Active US9242934B2 (en) 2009-05-02 2013-06-12 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/915,898 Active US9242934B2 (en) 2009-05-02 2013-06-12 Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses

Country Status (13)

Country Link
US (2) US8492590B2 (en)
EP (2) EP2246326A1 (en)
JP (1) JP5826167B2 (en)
KR (2) KR101862230B1 (en)
CN (1) CN102459163B (en)
BR (1) BRPI1015123B1 (en)
DK (1) DK2424835T3 (en)
ES (1) ES2548024T3 (en)
IL (1) IL216051A (en)
MX (2) MX367426B (en)
TW (1) TWI547473B (en)
WO (1) WO2010127786A1 (en)
ZA (1) ZA201108035B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008037631A1 (en) 2008-08-14 2010-02-18 Bayer Cropscience Ag Herbicide combination with dimethoxytriazinyl-substituted difluoromethanesulfonylanilides
WO2012028162A1 (en) * 2010-09-01 2012-03-08 Bayer Cropscience Ag Process for preparing oxindoles and ortho-substituted anilines and the use thereof as intermediates for syntheses
KR102057717B1 (en) * 2012-09-17 2019-12-19 바이엘 크롭사이언스 악티엔게젤샤프트 Continuous method for producing ortho-substituted anilines in a flow reactor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972894A (en) * 1973-04-27 1976-08-03 The Ohio State University Research Foundation Synthesis of oxindoles from anilines and β-thio carboxylic esters or amides
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US5663431A (en) * 1992-01-30 1997-09-02 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US20050090541A1 (en) * 2003-10-24 2005-04-28 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2708605A1 (en) 1993-07-30 1995-02-10 Sanofi Sa N-sulfonylindol-2-one derivatives, their preparation, pharmaceutical compositions containing them.
DE19521355A1 (en) 1995-06-12 1996-12-19 Hoechst Schering Agrevo Gmbh Sulfonamides, processes for their preparation and their use as herbicides and plant growth regulators
JP4445133B2 (en) * 1998-08-20 2010-04-07 大日本住友製薬株式会社 Oxindole derivatives
DE60019619T2 (en) * 1999-08-20 2006-03-02 Takeda Chemical Industries, Ltd. DIHYDROBENZOFURANDERIVATE, PROCESS FOR THEIR MANUFACTURE AND MEDIUM
AU2003218962B2 (en) * 2002-02-01 2008-09-25 F. Hoffmann-La Roche Ag Substituted indoles as alpha-1 agonists
US6906096B2 (en) * 2002-06-28 2005-06-14 Irm Llc 4,7-Disubstituted indoles and methods of making
CN100569076C (en) * 2004-05-12 2009-12-16 拜尔作物科学有限公司 Plant growth regulation
US20080280891A1 (en) 2006-06-27 2008-11-13 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
JP4770826B2 (en) 2007-11-22 2011-09-14 大日本印刷株式会社 Method for producing 2-oxindole derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972894A (en) * 1973-04-27 1976-08-03 The Ohio State University Research Foundation Synthesis of oxindoles from anilines and β-thio carboxylic esters or amides
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US5663431A (en) * 1992-01-30 1997-09-02 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US20050090541A1 (en) * 2003-10-24 2005-04-28 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
no references cited *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds

Also Published As

Publication number Publication date
EP2424835B1 (en) 2015-07-01
IL216051A0 (en) 2012-01-31
KR101782961B1 (en) 2017-09-28
US9242934B2 (en) 2016-01-26
US8492590B2 (en) 2013-07-23
ES2548024T3 (en) 2015-10-13
KR20120016123A (en) 2012-02-22
BRPI1015123B1 (en) 2021-05-04
WO2010127786A8 (en) 2011-11-10
EP2246326A1 (en) 2010-11-03
WO2010127786A1 (en) 2010-11-11
EP2424835A1 (en) 2012-03-07
MX2011011547A (en) 2011-11-29
JP2012526045A (en) 2012-10-25
JP5826167B2 (en) 2015-12-02
CN102459163B (en) 2015-05-13
CN102459163A (en) 2012-05-16
ZA201108035B (en) 2013-01-30
TWI547473B (en) 2016-09-01
US20130281711A1 (en) 2013-10-24
DK2424835T3 (en) 2015-10-05
BRPI1015123A2 (en) 2019-04-09
KR20170073738A (en) 2017-06-28
TW201111331A (en) 2011-04-01
IL216051A (en) 2015-03-31
MX367426B (en) 2019-08-21
KR101862230B1 (en) 2018-05-29

Similar Documents

Publication Publication Date Title
US9242934B2 (en) Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses
US9527808B2 (en) Continuous method for producing ortho-substituted anilines in a flow reactor
AU750368B2 (en) Process for preparing 4-substituted-1H-indole-3-glyoxamides
JP2002506460A (en) Method for producing 4-substituted-1H-indole-3-glyoxamide
WO2012028162A1 (en) Process for preparing oxindoles and ortho-substituted anilines and the use thereof as intermediates for syntheses
US6380397B1 (en) Process for preparing 4-substituted-1H-indole-3-glyoxamides
US6617460B1 (en) Process for preparing toluenesulfinates
US6570023B1 (en) Process for preparing toluenesulfinates
CA2949334A1 (en) Compounds of the 5-acylsulfanyl-histidine type as precursors of the corresponding 5-sulfanylhistidines and the disulfides thereofof
CZ466499A3 (en) Process for preparing 1H-indole glyoxamide being substituted in position 4 and intermediate for this preparation process
JP2002527421A (en) Method for producing 4-substituted-1H-indole-3-glyoxamide
JP2005232086A (en) Method for producing n-sulfenylamino acid ester compound

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAYER CROPSCIENCE AG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FORD, MARK JAMES;KARIG, GUNTER;REEL/FRAME:024591/0364

Effective date: 20100607

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER CROPSCIENCE AG;REEL/FRAME:034892/0286

Effective date: 20141217

AS Assignment

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, GERMANY

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 034892 FRAME: 0286. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:BAYER CROPSCIENCE AG;REEL/FRAME:035071/0680

Effective date: 20141217

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

AS Assignment

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, GERMANY

Free format text: CHANGE OF ADDRESS;ASSIGNOR:BAYER INTELLECTUAL PROPERTY GMBH;REEL/FRAME:064021/0344

Effective date: 20220401

AS Assignment

Owner name: BAYER CROPSCIENCE AKTIENGESELLSCHAFT, GERMANY

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:BAYER INTELLECTUAL PROPERTY GMBH;REEL/FRAME:064198/0823

Effective date: 20230523